HomeCompareSGMA vs MRK

SGMA vs MRK: Dividend Comparison 2026

SGMA yields 66.45% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SGMA wins by $832.5K in total portfolio value
10 years
SGMA
SGMA
● Live price
66.45%
Share price
$3.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$889.2K
Annual income
$224,520.35
Full SGMA calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SGMA vs MRK

📍 SGMA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSGMAMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SGMA + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SGMA pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SGMA
Annual income on $10K today (after 15% tax)
$5,647.84/yr
After 10yr DRIP, annual income (after tax)
$190,842.30/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, SGMA beats the other by $182,513.89/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SGMA + MRK for your $10,000?

SGMA: 50%MRK: 50%
100% MRK50/50100% SGMA
Portfolio after 10yr
$473.0K
Annual income
$117,159.24/yr
Blended yield
24.77%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SGMA
No analyst data
Altman Z
2.1
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SGMA buys
0
MRK buys
0
No recent congressional trades found for SGMA or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSGMAMRK
Forward yield66.45%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$889.2K$56.8K
Annual income after 10y$224,520.35$9,798.13
Total dividends collected$751.0K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SGMA vs MRK ($10,000, DRIP)

YearSGMA PortfolioSGMA Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$17,345$6,644.52$11,206$366.19+$6.1KSGMA
2$29,329$10,770.65$12,650$502.35+$16.7KSGMA
3$48,404$17,021.48$14,407$694.19+$34.0KSGMA
4$78,046$26,253.78$16,585$967.82+$61.5KSGMA
5$123,071$39,562.00$19,342$1,363.89+$103.7KSGMA
6$189,990$58,304.31$22,913$1,947.19+$167.1KSGMA
7$287,408$84,118.67$27,662$2,823.89+$259.7KSGMA
8$426,453$118,925.90$34,159$4,173.35+$392.3KSGMA
9$621,221$164,916.57$43,337$6,308.80+$577.9KSGMA
10$889,227$224,520.35$56,776$9,798.13+$832.5KSGMA

SGMA vs MRK: Complete Analysis 2026

SGMAStock

SigmaTron International, Inc. operates as an independent provider of electronic manufacturing services (EMS). Its EMS services include printed circuit board assemblies and completely assembled (box-build) electronic products. The company also offers automatic and manual assembly and testing of products; material sourcing and procurement services; manufacturing and test engineering support services; design services; warehousing and distribution services; and assistance in obtaining product approval from governmental and other regulatory bodies. In addition, the company offers electronic and electromechanical manufacturing solutions. It primarily serves industrial electronics, consumer electronics, and medical/life sciences industries in the United States, Mexico, China, Vietnam, and Taiwan. The company markets its services through independent manufacturers' representative organizations. SigmaTron International, Inc. was incorporated in 1993 and is headquartered in Elk Grove Village, Illinois.

Full SGMA Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SGMA vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SGMA vs SCHDSGMA vs JEPISGMA vs OSGMA vs KOSGMA vs MAINSGMA vs JNJSGMA vs ABBVSGMA vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.